Key result
Vascular access thrombosis is linked to ~6 mmHg higher 24-hour systolic BP variability in hemodialysis.
Why the study?
Studying hemodynamic markers for the development of vascular access thrombosis in maintenance hemodialysis patients is highly relevant due to known risk factors and prognostic implications.
Case-Control (n=90)
No
In patients on maintenance hemodialysis, increased systolic blood pressure variability, hypotensive episodes during dialysis, and pronounced right ventricular remodeling are significant hemodynamic markers associated with recurrent vascular access thrombosis.
Answers are grounded in this paper and cite their sources.
May signal higher thrombosis risk in hemodialysis; hypothesis-generating for BP variability or RV-targeted prevention trials.
Epidemiological research on vascular access insufficiency shows that the frequency of this complication increases with the age of patients, occurs more frequently in women than in men, and is more common in ethnic groups with higher incidence rates of diabetes mellitus and cardiovascular diseases [10,11]. Additionally, risk factors for vascular access insufficiency include an increased body mass index, background cardiovascular and peripheral vascular diseases, and diabetes mellitus. Another prognostically unfavorable situation is the need for HD before the maturation of the AV fistula (i.e., using other access options while the AV fistula matures) [14,15]. Based on these data, studying the hemodynamic markers for the development of vascular access thrombosis is highly relevant and formed the basis for this study.
No takes yet. Share an insight, caveat, or question.
Khatamov et al. (2026) conducted a case-control in Stage 5 Chronic Kidney Disease (n=90). Vascular access thrombosis vs. No vascular access thrombosis was evaluated on Systolic blood pressure variability (SBPV) over 24 hours (p=<0.001). Vascular access thrombosis in hemodialysis patients was significantly associated with higher 24-hour systolic blood pressure variability (22.10 vs 16.43 mmHg) and pronounced right ventricular dilation compared to those without thrombosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: